Juno strikes 3 deals to advance multiple myeloma combo treatment – FierceBiotech
FierceBiotech |
Juno strikes 3 deals to advance multiple myeloma combo treatment
FierceBiotech The deals, signed with Eli Lilly, OncoTracker and Fred Hutchinson Cancer Research Center, aim to boost the development of a multiple myeloma therapy combining BCMA-directed CAR–T cells in combination with gamma secretase inhibitors (GSIs). The enzyme … |
